Notificação de entrada na fase nacional - PCT
#1.3
01/06/2026
RPI 2870
Application data
Number
112025010163Type
Filing
Publication
PCT
US2023080387 Examination has not been requested yet. Without that request by 11/17/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:11/17/2026(84 days left)
Latest action published by the INPI: 01/06/2026. We update with every new RPI gazette, published weekly.
Applicants
RADIONETICS ONCOLOGY, INC.
US
Inventors
J. Z. (pessoa física)
US
J. L. (pessoa física)
US
Y. X. (pessoa física)
US
Y. Z. (pessoa física)
US
IPC Classification
Priority claims
US
63/384,873 · 11/23/2022
US
63/588,412 · 10/06/2023
Abstract
TERAPÊUTICOS DIRECIONADOS AO RECEPTOR DE NEUROPEPTÍDEO Y1 (NPY1R) E SEUS USOS. São descritos nesse relatório descritivo radioterapêuticos que visam células tumorais que expressam o receptor de neuropeptídeo Y1 (NPY1R) e seu uso no tratamento e/ou diagnóstico de câncer.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
01/06/2026
RPI 2870
#1.1
06/10/2025
RPI 2840
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.